Skip to main content

Table 1 Baseline characteristics

From: “As du Coeur” study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease

  Progressively autonomous group (n = 22) Supervised group
(n = 23)
p
Age, mean ± SD 62.5 ± 10.7 63.5 ± 8.1 0.64
Sex, n (%)    0.58
Male 21 (95.5) 21 (91.3)
Female 1 (4.5) 2 (8.7)
Weight, kg ± SD 82.4 ± 13.7 86.8 ± 12.3 0.27
BMI, kg/m2 ± SD 27.1 ± 4.0 29.5 ± 4.0 0.07
AC, cm ± SD 103.5 ± 12.3 106.0 ± 8.7 0.45
EQ5D, mean ± SD 0.828 ± 0.181 0.791 ± 0.161 0.48
6MWT distance, meters ±SD 600.8 ± 84.2 524.0 ± 88.1 0.0064
NYHA, n (%)
 I 11 (52.4) 6 (27.3) 0.32
 II 7 (33.3) 11 (50.0)
 III 3 (14.3) 4 (18.2)
 IV 1 (4.5)
Past medical history, n (%)
 Diabetes 4 (18.2) 3 (14.3) 0.73
 Hypertension 6 (27.3) 6 (26.1) 0.79
 Hyperlipidemia 16 (72.7) 15 (65.2) 0.59
 Moderate heart failure 1 (4.5) 7 (33.3) 0.0212
 Myocardial infarction 5 (22.7) 9 (40.9) 0.19
Revascularization, n (%)
 Angioplasty 15 (68.2) 13 (56.5) 0.42
 CABG 3 (13.6) 4 (19.0) 0.70
Cardiac function, n (%)
 LVEF < 50% 1 (4.8) 3 (14.3) 0.13
 LVEF > 50% 20 (95.2) 18 (85.7)
 Current smokers, n (%) 4 (18.2) 3 (14.3) 0.73
Drugs, n (%)
 Antiplatelet drugs 19 (86.4) 16 (69.6) 0.17
 Anticoagulants 4 (19.0) 0.0485
 Beta-blockers 11 (50.0) 11 (47.8) 0.88
  1. Abbreviations: AC Abdominal circumference, BMI Body Mass Index, CABG Coronary artery bypass graft, LVEF Left ventricular ejection fraction, 6MWT Six-minute walk test, SD Standard deviation